Back
Splash Beverage Group Vs. Keros Therapeutics Industry Stock Comparison
Sell
31
SBEV
Splash Beverage Group
Last Price:
0.34
Seasonality Move:
30.78%
Sell
22
KROS
Keros Therapeutics
Last Price:
55.23
Seasonality Move:
-16.78%
Sell
31
Splash Beverage Group (SBEV)
is a Sell
Is Splash Beverage Group a Buy, Sell or Hold?
- The current Splash Beverage Group [SBEV] share price is $0.33. The Score for SBEV is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- SBEV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $55.85. The Score for KROS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SBEV Stock Price Chart
What is Splash Beverage Group's stock price today?
-
The Splash Beverage Group share price today is $0.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SBEV is experiencing slight selling pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $55.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
SBEV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 31.29 | Sell |
| Chaikin Money Flow: | -38357 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.32 - 0.46) | Sell |
| Bollinger Bands (100): | (0.4 - 0.6) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.81 | Sell |
| Relative Strength Index (14 RSI): | 34.82 | Sell |
| Chaikin Money Flow: | -197366 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.34 - 66.2) | Sell |
| Bollinger Bands (100): | (41.34 - 66.16) | Buy |
SBEV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.33 | Sell |
| 20-day SMA: | 0.37 | Sell |
| 50-day SMA: | 0.47 | Sell |
| 200-day SMA: | 0.61 | Sell |
| 8-day EMA: | 0.34 | Sell |
| 20-day EMA: | 0.37 | Sell |
| 50-day EMA: | 0.43 | Sell |
| 200-day EMA: | 0.64 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.62 | Sell |
| 20-day SMA: | 61.97 | Sell |
| 50-day SMA: | 63.5 | Sell |
| 200-day SMA: | 44.01 | Buy |
| 8-day EMA: | 58.73 | Sell |
| 20-day EMA: | 61.02 | Sell |
| 50-day EMA: | 60.58 | Sell |
| 200-day EMA: | 49.59 | Buy |
Splash Beverage Group Earnings Growth & SBEV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.12 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
Splash Beverage Group Technical Analysis
| Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||